These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11983147)

  • 1. [The prospect on the technique of test for blood donor infected with hepatitis C virus during the infectious window period].
    Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):159-60. PubMed ID: 11983147
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of an 'in-house' PCR assay validated for the detection of hepatitis C virus RNA.
    Lombardi GR; Oviedo A; Freytes F; Zarzur J; Guglielmone H; Vitali MS
    Transfus Med; 2008 Oct; 18(5):317-9. PubMed ID: 18937742
    [No Abstract]   [Full Text] [Related]  

  • 3. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Poland.
    Brojer E
    Vox Sang; 2005 Nov; 89(4):267-8. PubMed ID: 16262764
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT).
    O'Riordan J; Williams P; Donnellan J
    Vox Sang; 2005 Nov; 89(4):266. PubMed ID: 16262763
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens.
    Padley DJ; Lucas SB; Saldanha J
    Transplantation; 2003 Jul; 76(2):432-4. PubMed ID: 12883207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of serologically negative plasma pools for hepatitis C virus by nucleic acid amplification testing in Croatia, 2001-2003.
    Forcić D; Zgorelec R; Kosutić-Gulija T; Ivancić J; Baricević M; Lupret L; Mazuran R
    Transfus Apher Sci; 2005 Oct; 33(2):175-9. PubMed ID: 16122985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
    Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis confirmation of transfusion-transmitted hepatitis C by red blood cells that tested negative by minipool hepatitis C virus nucleic acid testing.
    Grabarczyk P; Gronowska A; Brojer E; Letowska M; Radziwon P
    Transfusion; 2007 Jun; 47(6):1102-4. PubMed ID: 17524106
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study.
    Seme K; Mocilnik T; Fujs K; Babic DZ; Todorović A; Fras-Stefan T; Poljak M
    J Virol Methods; 2007 Mar; 140(1-2):218-21. PubMed ID: 17157928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regarding 'Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective' by Loubière et al.
    Franklin IM
    Vox Sang; 2002 Jan; 82(1):50-1. PubMed ID: 11856469
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C test results do not justify claim of test equivalence nor of prolonged seroconversion.
    Caspari G
    Vox Sang; 2005 Apr; 88(3):205. PubMed ID: 15787733
    [No Abstract]   [Full Text] [Related]  

  • 16. [HCV RNA assessment by PCR technique for screening post-transfusion HCV infection among blood donors].
    Xing W; Xu H; Ma R; Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):211-2. PubMed ID: 12113682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus RNA and nucleic acid testing].
    Ohishi W; Chayama K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():450-3. PubMed ID: 20942101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.